These findings support a link between lncRNA MCM3AP‐AS1 and miR‐194‐5p/FOXA1 as well as provide evidence for the potential use of MCM3AP‐AS1 as a prognostic biomarker and therapeutic target in HCC.81 This evidence concerns the gene FOXA1 and hepatocellular carcinoma.